| scholarly article | Q13442814 |
| P2093 | author name string | Michael Schaefer | |
| Solveig Grossmann | |||
| H Peter Reusch | |||
| Alejandra Pérez Sastre | |||
| P2860 | cites work | Atherosclerosis | Q24644573 |
| Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF | Q24672346 | ||
| Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
| Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro | Q28569565 | ||
| Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1 | Q28576209 | ||
| Osmotic stress induces HB-EGF gene expression via Ca(2+)/Pyk2/JNK signal cascades in rat aortic smooth muscle cells | Q28579688 | ||
| Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
| Coordinating ERK/MAPK signalling through scaffolds and inhibitors | Q29618995 | ||
| EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF | Q29619098 | ||
| AP-1: a double-edged sword in tumorigenesis | Q30014831 | ||
| Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall | Q33537227 | ||
| Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling | Q33930863 | ||
| Heparin-binding EGF-like growth factor: a juxtacrine growth factor | Q34013847 | ||
| Vascular smooth muscle growth: autocrine growth mechanisms | Q34294052 | ||
| Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. | Q34516136 | ||
| Regulatory mechanisms and function of ERK MAP kinases | Q35999767 | ||
| Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype | Q36127997 | ||
| Mechanisms of disease: atherosclerosis in autoimmune diseases | Q36577423 | ||
| The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. | Q36649442 | ||
| Regulation of vascular inflammation and remodeling by ETS factors | Q36661332 | ||
| In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice | Q36706331 | ||
| AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells. | Q38321751 | ||
| Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer | Q38348367 | ||
| Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. | Q40022010 | ||
| Preparation of functional smooth muscle cells from the rabbit aorta | Q40190227 | ||
| Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance | Q40227623 | ||
| The chemotherapeutic agent VP16 increases the stability of HB-EGF mRNA by a mechanism involving the 3'-UTR. | Q40228622 | ||
| Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. | Q41481604 | ||
| Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth | Q41661319 | ||
| Inflammation and atherosclerosis | Q43418792 | ||
| Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2. | Q43554536 | ||
| Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells | Q43666441 | ||
| TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. | Q52961034 | ||
| Gbeta gamma mediate differentiation of vascular smooth muscle cells. | Q52965356 | ||
| ERK1/2-dependent contractile protein expression in vascular smooth muscle cells | Q73094670 | ||
| Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha | Q73565789 | ||
| Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells | Q74254758 | ||
| Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells | Q74424561 | ||
| Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases | Q80975510 | ||
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 25871-25878 | |
| P577 | publication date | 2008-07-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Requirement of an intermediate gene expression for biphasic ERK1/2 activation in thrombin-stimulated vascular smooth muscle cells | |
| P478 | volume | 283 |
| Q37024807 | Biphasic activation of extracellular signal-regulated kinase (ERK) 1/2 in epidermal growth factor (EGF)-stimulated SW480 colorectal cancer cells |
| Q37411594 | Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling. |
| Q33802598 | IκB kinase β regulates epithelium migration during corneal wound healing |
| Q34114355 | Protein targets of inflammatory serine proteases and cardiovascular disease |
| Q43098985 | Role of the cytoskeleton in Cd2+-induced death of mouse mesangial cells |
| Q91804312 | Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling |
Search more.